收回:氧化应激和肺部变化在实验性肝硬化中的肝硬化
Oxidative medicine and cellular longevity
|January 7, 2026
概括
这篇文章已被撤回. 原来的研究,DOI: 10.1155/2012/486190,不再被认为是有效的或科学记录的一部分.
科学领域:
- 科学出版物的撤回通知.
背景情况:
- 这个条目是对以前发表的文章的撤回通知.
研究的目的:
- 为了正式撤回DOI标识的物品: 10.1155/2012/486190.0.
主要方法:
- 由出版商启动的正式撤回程序.
主要成果:
- 这篇文章DOI: 10.1155/2012/486190 正式撤回.
结论:
- 撤回的文章的内容不应该被引用或引用.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
210
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
210
Phase I Oxidative Reactions: Overview
703
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
703


